ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,025Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 944

$474K Total Retail Price of All Prescriptions

Rank: 234 out of 944

499 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 499 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 499 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,499 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 529 426 1 1
AMLODIPINE BESYLATE 492 416 2 5
LEVOTHYROXINE SODIUM 424 357 3 2
LISINOPRIL 388 347 4 3
METOPROLOL SUCCINATE 268 226 5 14
HYDROCHLOROTHIAZIDE 243 200 6 9
FUROSEMIDE 206 167 7 6
ATORVASTATIN CALCIUM 205 173 8 13
POTASSIUM CHLORIDE 189 136 9 15
ZOLPIDEM TARTRATE 177 144 10 25
LOSARTAN POTASSIUM 168 162 11 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 137 12 29
PRAVASTATIN SODIUM 154 134 13 17
WARFARIN SODIUM 147 124 14 7
OMEPRAZOLE 146 119 15 4
LOSARTAN-HYDROCHLOROTHIAZIDE 145 131 16 54
METFORMIN HCL ER 135 112 17 49
METOPROLOL TARTRATE 131 126 18 8
SERTRALINE HCL 117 112 19 23
HYDROCODONE-ACETAMINOPHEN 110 90 S3 20 10
ALENDRONATE SODIUM 104 90 21 20
ALLOPURINOL 102 84 22 22
TRIAMTERENE-HCTZ 99 75 23 33
LANTUS 91 82 24 46
CITALOPRAM HBR 89 78 25 19
CARVEDILOL 88 67 26 30
ATENOLOL 87 87 27 11
LOVASTATIN 83 82 28 26
DILTIAZEM ER 78 78 29 88
ADVAIR DISKUS 71 56 30 31
TRAMADOL HCL 66 37 31 21
SYNTHROID 63 54 32 82
FLUOXETINE HCL 63 41 32 48
CRESTOR 62 56 34 28
INSULIN SYRINGE 61 52 35 121
NAMENDA 59 59 36 37
FLUTICASONE PROPIONATE 57 30 37 40
GLYBURIDE-METFORMIN HCL 55 47 R 38 132
LIPITOR 52 46 39 91
KLOR-CON 10 50 20 40 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.